. Characteristics of women with peripartum cardiomyopathy by participation in the clinical follow-up study.
Participated in study follow-up, n=28
Did not participate in study follow-up, n=33 P value Age at index delivery, 2 (7) 4 (13) 5 (18) 5 (18) 3 (11) 1 (4) 3 (11) 1 (4) 2 (7) 5 (15) 3 (9) 2 (6) 5 (15) 3 (9) 2 (6) 3 (9) 4 (13) PPCM, peripartum cardiomyopathy; LVEF, left ventricular ejection fraction *Major adverse events included death, heart transplantation, mechanical circulatory assist device or persistent heart failure with LVEF < 35 % after 12 months. †Complete recovery of LVEF after 12 months was defined as LVEF ≥ 55 % 
